Even so, the proportion of MMR-deficient breast carcinomas was significantly higher compared to breast carcinomas from non-carriers (Table 1) suggesting that MMR defects do play a role in breast tumorigenesis in MMR gene mutation carriers. This evidence concerns the gene MRC1 and breast carcinoma.